Europe — EMA

Olmicombi (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Olmicombi, is a angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension in adult patients.

Olmesartan Medoxomil, Hydrochlorothiazide

Request sourcing

Pack/s

What is Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan medoxomil, the active ingredient in Olmicombi, is a angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Olmicombi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmicombi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil, Hydrochlorothiazide used for?

Olmicombi combines the combination of ol ...

What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?

Common ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →